Form 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 


FORM 8-K

 


CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): September 25, 2006

 


AmerisourceBergen Corporation

(Exact name of Registrant as specified in its charter)

 


 

Delaware   1-16671   23-3079390

(State or Other Jurisdiction of

Incorporation or Organization)

  Commission File Number  

(I.R.S. Employer

Identification Number)

 

1300 Morris Drive Chesterbrook, PA   19087
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: (610) 727-7000

N/A

(Former name or former address, if changed since last report.)

 


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 



Item 8.01. Other Events.

On September 25, 2006, AmerisourceBergen Corporation issued a news release announcing that it had entered into an agreement to purchase all of the outstanding stock of Health Advocates, Inc., a Florida corporation (“Health Advocates”), for approximately $83 million in cash. Health Advocates is a privately-held provider of Medicare set-aside cost containment services to insurance payors primarily within the workers’ compensation industry. Health Advocates generated revenues of approximately $20 million over the last twelve months. A copy of the news release is filed as Exhibit 99.1 to this report and incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(c) Exhibits.

 

  99.1 News Release regarding Health Advocates, Inc.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  AMERISOURCEBERGEN CORPORATION
Date: September 25, 2006   By:  

/s/ Michael D. DiCandilo

  Name:   Michael D. DiCandilo
  Title:   Executive Vice President
    and Chief Financial Officer